FOR IN VITRO RESEARCH & LABORATORY USE ONLYCASH ON DELIVERY AVAILABLEFOR IN VITRO RESEARCH & LABORATORY USE ONLYCASH ON DELIVERY AVAILABLE

Home Shop by Concern Growth Hormone & Lean Mass

Concern · Growth Hormone & Lean Mass

GH-axis, recovery & body-composition peptides.

Research peptides that stimulate endogenous growth-hormone release through two complementary mechanisms — GHRH analogues (CJC-1295 No DAC, Tesamorelin) and GHRPs (Ipamorelin). Commonly paired in research protocols for synergistic GH pulse amplification.

CJC-1295 (No DAC) listings

GHRH analogue — pulsatile GH release.

Ipamorelin listings

Selective GHRP — minimal cortisol / prolactin.

Tesamorelin listings

FDA-approved stabilised GHRH analogue.

Why this concern

CJC-1295 No DAC is a stabilised GHRH analogue with four amino-acid substitutions that extend plasma half-life while preserving pulsatile GH release. Teichman, Ionescu and Alba (JCEM 2006) characterised its 30-minute half-life and GH-axis effects. Read the full CJC-1295 guide →

Ipamorelin is a selective GHRP (ghrelin-mimetic) that activates GHSR-1a with minimal cortisol or prolactin elevation — a cleaner profile than GHRP-6 or GHRP-2. Its mechanism is complementary to GHRH analogues, which is why the CJC-1295 + Ipamorelin stack is widely referenced in GH-axis research. Read the full Ipamorelin guide →

Tesamorelin is an FDA-approved GHRH analogue, primarily indicated for visceral-fat research but also referenced for broader GH-axis stimulation. Read the full Tesamorelin guide →

For in vitro research and laboratory use only. Not for human or veterinary consumption. Not intended to diagnose, treat, cure, or prevent any disease.